4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001140361-16-046816
Director sold 11,520 shares at an average $38.79 ($446,890)
- Director acquired 11,520 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bailey Sue · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-01-04 | Exercise or conversion : show line 1 in the form | +5,760 | $11.67 | $67,219 | 34,260 | D |
| 2016-01-04 | Sale : show line 2 in the form | −5,760 | $38.97 | $224,467 | 28,500 | D |
| 2016-01-04 | Exercise or conversion : show line 3 in the form | +2,880 | $16.13 | $46,454 | 31,380 | D |
| 2016-01-04 | Sale : show line 4 in the form | −2,880 | $38.77 | $111,658 | 28,500 | D |
| 2016-01-04 | Exercise or conversion : show line 5 in the form | +2,880 | $22.02 | $63,418 | 31,380 | D |
| 2016-01-04 | Sale : show line 6 in the form | −2,880 | $38.46 | $110,765 | 28,500 | D |
| Open-market sales · 11,520 sh · avg $38.79 · $446,890 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-01-04 | Exercise or conversion : show line 7 in the form Stock Option | −5,760 | $11.67 | 2019-05-20 | 5,760 | 2,880 | D |
| 2016-01-04 | Exercise or conversion : show line 8 in the form Stock Option | −2,880 | $16.13 | 2020-05-19 | 2,880 | 2,880 | D |
| 2016-01-04 | Exercise or conversion : show line 9 in the form Stock Option | −2,880 | $22.02 | 2021-05-18 | 2,880 | 4,320 | D |
Loading xslF345X03/doc1.xml…